| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.25 | 0.02 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.41 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |